Search

A recent report from Teerthanker Mahaveer Dental College and Research Centre in Uttar Pradesh, India discusses the diagnostic challenges of calcifying odontogenic cyst (COC), a rare developmental lesion that arises from the odontogenic epithelium. COC is characterized by an overgrowth of odontogenic epithelium and the presence of ghost cells and calcifications. While it can occur anywhere in the oral cavity, it is more frequently found in the anterior mandible and maxilla. This case report focuses on the clinical and radiographic features, as well as the management of COC. The research highlights that COC can occur at any age, but is most commonly seen in individuals in their 20s to 30s. [Extracted from the article]

A recent study conducted by the Post Graduate Institute of Dental Sciences in Haryana, India, has provided new insights into a rare benign neoplasm called dentinogenic ghost cell tumor (DGCT). DGCT is a form of calcifying odontogenic cyst (COC) characterized by ghost cells. Although it is a benign tumor, it can exhibit aggressive behavior and has a low recurrence rate. The study presents the case of a 51-year-old male with DGCT and provides a review of similar cases in the past. The research emphasizes the importance of long-term monitoring for central DGCT patients to detect recurrence. [Extracted from the article]

A recent report from the University of the Republic in Montevideo, Uruguay explores the association between hypoxia (a lack of oxygen supply) and ameloblastomas, which are benign tumors in the maxillofacial region. The study found that hypoxia is linked to the invasive potential, progression, and malignant transformation of these tumors. The research sheds light on the mechanisms and implications of this association. For more information, readers can refer to the article "Comprehensive Insights Into the Understanding of Hypoxia In Ameloblastoma" published in Histology and Histopathology. [Extracted from the article]

A recent study conducted at Gregorio Maranon General University Hospital in Madrid, Spain, focused on the surgical treatment of a rare, benign odontogenic tumor called a calcifying epithelial odontogenic tumor. The study reported a case of aggressive late recurrence of this tumor in a 64-year-old female patient, two decades after initial surgical removal. The researchers used new technologies such as virtual surgery, custom reconstruction plates, and intraoperative computed tomography to perform a segmental mandibulectomy and immediate reconstruction using a vascularized free fibula flap. The study concluded that these new technologies can improve precision and reduce morbidity in implant-supported rehabilitation. [Extracted from the article]

A recent study conducted at Government Dental College in Kerala, India, focused on cementoblastomas, which are benign odontogenic tumors. The researchers presented a case report of a 14-year-old male patient who experienced recurrent swelling in the right mandibular posterior region. Despite surgical removal of the tumor mass, the lesion recurred, leading the researchers to recommend en-bloc resection on the right side of the mandible for treatment and management. This study provides valuable insights into the treatment of cementoblastomas. [Extracted from the article]

Researchers at QST Hospital have conducted a study on the use of carbon-ion radiotherapy (C-ion RT) for clear cell odontogenic carcinomas (CCOC), a rare type of malignant tumor. The standard treatment for CCOC is surgical resection followed by adjuvant radiotherapy. However, in cases where surgery is not possible, the role of radiotherapy remains unknown. The study presented two cases where C-ion RT was administered to patients with inoperable CCOC, showing promising results in controlling the tumors. The researchers concluded that C-ion RT may be an effective treatment option for patients with inoperable CCOC. [Extracted from the article]

A recent study conducted at Soroti University in Uganda examined the immunohistochemical expression of Ki-67 and p53 in patients with ameloblastoma, a locally aggressive tumor with a high recurrence rate. The study found that 52.5% of patients had Ki-67 expression and 85.0% had p53 expression. Recurrence was associated with the conventional histological type, segmental resection, tumor size, and high p53 expression. The study concluded that almost half of the cases in the study experienced recurrence, and p53 expression was significantly higher than Ki-67 expression. For more information, the full study can be accessed through the Oman Medical Journal. [Extracted from the article]

Researchers from Manipal College of Dental Sciences in Karnataka, India have published new findings on odontogenic cysts. The study focused on the expression of two proteins, SALL4 and fascin, in various types of odontogenic cysts and tumors. The researchers found that fascin was expressed in ameloblastomas, suggesting a role in motility and localized invasion. SALL4 expression was observed in the cytoplasm of odontogenic cysts and tumors, but further validation is needed to understand its significance. This research provides valuable insights into the molecular characteristics of odontogenic cysts and tumors. [Extracted from the article]

A recent study conducted at St. Mary's Hospital in the Democratic Republic of the Congo explored the presence of the Lassa virus in odontogenic bone tumor (OT) tissues. OT is a rare pathology that is more common in developing countries and can cause serious deformities if not treated promptly. The researchers found that 81.5% of the tissues collected from nine OT patients tested positive for the presence of the Lassa virus. These preliminary findings suggest a possible link between the Lassa virus and the development of OT. Further research is needed to confirm this hypothesis. [Extracted from the article]

A new study conducted by researchers at Shiraz University of Medical Sciences in Iran evaluated the expression of the protein Paxillin (PXN) in different types of odontogenic cysts and tumors. The study found that PXN was present in the cytoplasm of tumor cells and the epithelial layer of cysts. However, there was no statistical difference in PXN expression between different types of cysts or between cysts and tumors. The researchers concluded that PXN expression is not related to the biological behaviors of odontogenic lesions. [Extracted from the article]

A recent study conducted at Lausanne University Hospital in Switzerland has explored the potential benefits of targeted therapy for ameloblastomas, a benign but aggressive tumor. The study reviewed 13 relevant studies and found that nearly all patients treated with MAPK inhibitor therapies showed a positive treatment response, with some achieving complete remission. The side effects of the therapy were mostly mild to moderate. This research suggests that targeted therapy could be a less invasive yet effective alternative to invasive surgical treatments for ameloblastomas, and further research into molecular-targeted therapies is needed. [Extracted from the article]

A new report from researchers at Manipal College of Dental Sciences in India provides details on the expression of two proteins, SALL4 and fascin, in various types of odontogenic cysts and tumors. The study found that fascin was expressed in ameloblastomas, suggesting a role in motility and localized invasion. SALL4 expression was observed in the cytoplasm of odontogenic cysts and tumors, but further validation is needed to understand its significance. The research highlights the need for further exploration of these proteins and their functional properties in different lesions. [Extracted from the article]

Copyright of Tandlaegebladet is the property of Tandlaegeforeningen and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Quintessenz Zahnmedizin is the property of Quintessenz Verlags GmbH and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

A recent study conducted in Haryana, India, has provided new insights into a rare variant of central ameloblastoma called desmoplastic ameloblastoma. This type of tumor is characterized by benign, locally invasive growth with low recurrence rates and unique histological features. The study reports a case of desmoplastic ameloblastoma in the mandible of a 21-year-old male with a painless swelling in the anterior region of the maxilla. This research is significant as there have been only a few published cases of adult patients affected by desmoplastic ameloblastoma. The study has been peer-reviewed and can be accessed through the Indian Journal of Cancer. [Extracted from the article]

A new report from King Saud bin Abdulaziz University for Health Sciences in Saudi Arabia provides valuable insights into the frequency, demographics, treatment, and outcomes of odontogenic tumors (OTs) in the country. The study analyzed data from three tertiary medical centers and identified 92 OT cases. The majority of OTs occurred in the mandible, with ameloblastoma being the most common type. The study also found that bone resection was the most common treatment modality, and 11.5% of cases exhibited recurrence. This research contributes to a better understanding of the epidemiology and characteristics of OTs in Saudi Arabia. [Extracted from the article]

A new study on ameloblastomas, a rare odontogenic tumor, has been published by a researcher from the College of Dental Surgery. The study focuses on a case of adenoid ameloblastoma, which is a hybrid lesion with histopathological features of both ameloblastoma and adenomatoid odontogenic tumor. The research highlights the importance of updating the classification and diagnostic criteria for this pathology. The study aims to enhance understanding of the clinical characteristics and diverse histopathological morphology of these lesions. [Extracted from the article]

Researchers from JSS Dental College and Hospital in Karnataka, India, have published a review and case report on a rare variant of ameloblastoma, a tumor of the oral cavity. The study focuses on desmoplastic ameloblastoma (DA), which has a low incidence rate. The researchers discuss the clinical, radiographic, and histopathologic findings of a DA case in a 35-year-old woman. They conclude that clinicians should consider DA as a differential diagnosis for patients with swelling in the premolar region of the maxilla. The full article can be accessed for free through the provided link. [Extracted from the article]

A recent study conducted in Baghdad, Iraq examined the clinical and pathological features of odontogenic tumors over an 11-year period. The study analyzed tissue blocks from patients diagnosed with odontogenic tumors and collected data on age, gender, location, and histopathological information. The most common type of tumor was solid ameloblastoma, and mandibular tumors were more common than maxillary tumors. The study provides valuable information for early diagnosis and intervention. [Extracted from the article]

A recent study conducted in Tamil Nadu, India, examined the expression of calretinin in odontogenic cysts and tumors. The researchers found that ameloblastomas showed a high level of calretinin expression compared to other cysts and tumors. This suggests that calretinin could be a specific marker for ameloblastomas and may help in identifying the aggressiveness of various odontogenic tumors. The study provides valuable insights into the diagnosis and treatment of these conditions. [Extracted from the article]

A study conducted at the University of Pennsylvania has found that immunohistochemical staining of formalin-fixed paraffin-embedded tissues can be a low-cost and effective method for detecting the BRAFV600E mutation in ameloblastoma, an aggressive jaw tumor. The researchers compared this method to Direct Sanger sequencing and Amplification Refractory Mutation System-PCR and found that immunohistochemistry had a higher sensitivity and specificity. The study suggests that using a combination of immunohistochemistry and molecular testing can reduce equivocal results and improve patient selection for BRAFV600E-inhibitor therapies. [Extracted from the article]

Researchers at Sinhgad Dental College and Hospital in Maharashtra, India, have reported a rare case of a hybrid tumor in the maxilla. The tumor is a combination of odontogenic fibromyxoma and central giant cell granuloma, two locally aggressive benign tumors. This is the first reported case of this hybrid lesion, and the researchers provide a brief review of its clinical presentation, radiographic features, histological features, and management. The findings contribute to the understanding of these rare tumors and may have implications for their diagnosis and treatment. [Extracted from the article]

Copyright of Tandlaegebladet is the property of Tandlaegeforeningen and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

A recent report from Gazi University in Ankara, Turkey, discusses the use of BRAF-inhibitors in the treatment of ameloblastomas, a locally invasive and aggressive odontogenic tumor. The report presents a case study of a 42-year-old male patient with recurrent ameloblastoma who received neoadjuvant therapy with Dabrafenib and Trametinib, resulting in a significant reduction in tumor size. The researchers suggest that neoadjuvant therapy with BRAF-inhibitors or BRAF-MEK-inhibitors could be an effective approach to reduce the size of mandibulary ameloblastomas and minimize post-surgical complications. Further research is needed to explore this treatment modality. [Extracted from the article]

A recent study conducted by researchers at Zhejiang University School of Medicine in Hangzhou, China, explores the rare occurrence of hypercalcemia in patients with ameloblastoma, a benign odontogenic tumor. The study presents a case report of a 26-year-old male with giant ameloblastoma of the mandible, accompanied by hypercalcemia, renal dysfunction, anemia, and cachexia. The researchers emphasize the importance of selecting the appropriate operation for improving patient prognosis and describe the implementation of a multi-disciplinary team meeting to design an individualized treatment strategy. The patient ultimately underwent successful tumor resection and reconstruction, with no recurrence of the tumor or hypercalcemia observed during the 5-year follow-up period. [Extracted from the article]

A recent report from Banaras Hindu University discusses the research on ameloblastomas, which are the second most common odontogenic tumor after odontoma. Ameloblastomas are locally aggressive and have a high tendency of recurrence. They arise from the remnants of odontogenic epithelium, odontogenic cystic lining, and the basal layer of the oral mucosa. This type of tumor accounts for 1% of all odontogenic cysts and tumors, and 9-11% of various odontogenic tumors of the jaw. The researchers present a rare case of acanthomatous ameloblastoma involving the mandibular anterior region. [Extracted from the article]

Keywords: Health and Medicine; Oral Pathology EN Health and Medicine Oral Pathology 3467 3467 1 10/09/23 20231013 NES 231013 2023 OCT 13 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on agriculture. According to the news editors, the research concluded: "The general pathologists recognized oral pathology as a specialty and feel the need for an oral pathologist opinion in diagnosis. [Extracted from the article]

Keywords: Biomarkers; Diagnostics and Screening; Health and Medicine; Stem Cell Research EN Biomarkers Diagnostics and Screening Health and Medicine Stem Cell Research 241 241 1 09/19/23 20230919 NES 230919 2023 SEP 22 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- Investigators publish new report on biomarkers. Biomarkers, Diagnostics and Screening, Health and Medicine, Stem Cell Research. [Extracted from the article]

Keywords: Health and Medicine EN Health and Medicine 1502 1502 1 09/11/23 20230915 NES 230915 2023 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on agriculture is the subject of a new report. Keywords for this news article include: Department of Oral Medicine and Oral Surgery, Health and Medicine. [Extracted from the article]

Keywords for this news article include: National Institute of Medical Sciences, Rajasthan, India, Asia, Epidemiology, Pathology and Oncology. Keywords: Epidemiology; Oncology; Pathology and Oncology EN Epidemiology Oncology Pathology and Oncology 700 700 1 09/11/23 20230912 NES 230912 2023 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Researchers detail new data in pathology and oncology. Epidemiology, Oncology, Pathology and Oncology. [Extracted from the article]

Keywords for this news article include: Shahrekord University of Medical Sciences, Shahrekord, Iran, Asia, Health and Medicine, Craniomaxillofacial Research. Keywords: Craniomaxillofacial Research; Health and Medicine EN Craniomaxillofacial Research Health and Medicine 7081 7081 1 08/28/23 20230901 NES 230901 2023 SEP 1 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on craniomaxillofacial research. [Extracted from the article]

Dental Diseases and Conditions, Dentistry, Health and Medicine, Impacted Tooth, Orthodontics, Pediatrics Keywords: Dental Diseases and Conditions; Dentistry; Health and Medicine; Impacted Tooth; Orthodontics; Pediatrics EN Dental Diseases and Conditions Dentistry Health and Medicine Impacted Tooth Orthodontics Pediatrics 914 914 1 08/28/23 20230903 NES 230903 2023 SEP 3 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Investigators discuss new findings in impacted tooth. [Extracted from the article]

Keywords for this news article include: Eskisehir Osmangazi Universitesi, Inflammation, Health and Medicine. Keywords: Health and Medicine; Inflammation EN Health and Medicine Inflammation 5016 5016 1 05/29/23 20230602 NES 230602 2023 JUN 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on agriculture. [Extracted from the article]

Keywords: Dentistry; Health and Medicine EN Dentistry Health and Medicine 3265 3265 1 03/27/23 20230331 NES 230331 2023 MAR 31 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on dentistry. Keywords for this news article include: Shahid Beheshti University of Medical Sciences, Tehran, Iran, Asia, Dentistry, Health and Medicine. [Extracted from the article]

Adenomas, Follicular Adenoma, Health and Medicine, Oncology Keywords: Adenomas; Follicular Adenoma; Health and Medicine; Oncology EN Adenomas Follicular Adenoma Health and Medicine Oncology 7071 7071 1 03/23/23 20230317 NES 230317 2023 MAR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in follicular adenoma. [Extracted from the article]

Keywords: Ameloblastomas; Cancer; Health and Medicine; Oncology EN Ameloblastomas Cancer Health and Medicine Oncology 2023 FEB 14 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Data detailed on ameloblastomas have been presented. According to news originating from Wuhan, People's Republic of China, by NewsRx correspondents, research stated, "Ameloblastoma (AM) is a rare epithelium-derived odontogenic tumor, mostly involving the mandible and less often the maxilla.". [Extracted from the article]

Oncology - Myxomas Fresh data on myxomas are presented in a new report. According tonews reporting originating from Maharashtra, India, by NewsRxcorrespondents, research stated, "Odontogenic myxoma (OM) is a rarebenign odontogenic tumor characterized by stellate and spindle-shapedcells dispersed in an abundant myxoid extracellular matrix.". [Extracted from the article]

The article describes several oral pathology cases. It includes the case of a 54-year-old female patient found to have a tissue-colored raised fluctuant mass on the left side of the lingual frenum found to be a mcus retention cyst, and another is the case of a 22-year-old female patient who suspected that her wisdom tooth is infected by was later diagnosed as dentigerous cyst.

The article focuses on the diagnosis of peripheral odontogenic ossifying fibroma in a 51-year old female patient presented with lesion in the anterior region of her mouth. It states that such disease is a reactionary lesion that developed from submucosal connective tissue and periodontal ligament. It describes the characteristics of peripheral ossifying fibromas. The author states that the treatment of choice for the disease is excision of the lesion with periodontal ligament.

Presents a case study on a complex odontoma. Clinical features of odontoma; Radiographic appearance of the compound and complex odontomas; Treatment.

Presents a case study about a male teenager with adenomatoid odontogenic tumor (AOT). Information on AOT; Ages of individuals often diagnosed with AOT; Treatment for the disease.